MBX Biosciences, Inc. MBX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $75.23M-5.0% | $79.16M+6.1% | $74.62M+3.5% | $72.1M+4.8% | $68.77M+19.8% | ||
| $23.56M+24.7% | $18.9M+16.3% | $16.25M+12.4% | $14.46M+14.4% | $12.64M+17.2% | ||
| $98.79M+0.8% | $98.06M+7.9% | $90.87M+5.0% | $86.56M+6.3% | $81.41M+19.4% | ||
| $98.79M+0.8% | $98.06M+7.9% | $90.87M+5.0% | $86.56M+6.3% | $81.41M+19.4% | ||
| -$98.79M-0.8% | -$98.06M-7.9% | -$90.87M-5.0% | -$86.56M-6.3% | -$81.41M-19.4% | ||
| $12.18M+9.9% | $11.08M+6.8% | $10.38M+8.8% | $9.54M+20.1% | $7.94M+26.7% | ||
| -$86.64M+0.4% | -$87M-8.1% | -$80.5M-4.5% | -$77.02M-4.8% | -$73.47M-18.6% | ||
| -$2.16+8.9% | -$2.37— | —— | —— | —— | ||
| -$2.16+8.9% | -$2.37— | —— | —— | —— | ||
| 150.7M+9.6% | 137.6M+23.2% | 111.7M+32.9% | 84M+62.1% | 51.8M+164% | ||
| 150.7M+9.6% | 137.6M+23.2% | 111.7M+32.9% | 84M+62.1% | 51.8M+164% | ||
| -$87.27M-0.6% | -$86.74M-7.8% | -$80.45M-4.5% | -$76.99M-4.9% | -$73.41M-18.5% | ||
| $12.18M+9.9% | $11.08M+6.8% | $10.38M+8.8% | $9.54M+20.1% | $7.94M+26.7% | ||
| —— | $54K-2.3% | $55.25K-2.2% | $56.5K-2.2% | $57.75K-2.1% | ||
| -$605K-312% | $285K+166% | $107K+25.9% | $85K-26.1% | $115K+113% | ||
| -$98.79M-0.8% | -$98.06M-7.9% | -$90.87M-5.0% | -$86.56M-6.3% | -$81.41M-19.4% | ||
| -$98.47M-0.8% | -$97.72M-7.9% | -$90.54M-5.0% | -$86.22M-6.3% | -$81.07M-19.4% | ||
| -$98.47M-0.8% | -$97.72M-7.9% | -$90.54M-5.0% | -$86.22M-6.3% | -$81.07M-19.4% | ||
| -$98.79M-0.8% | -$98.06M-7.9% | -$90.87M-5.0% | -$86.56M-6.3% | -$81.41M-19.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is MBX Biosciences, Inc. profitable?
- MBX Biosciences, Inc. is not currently profitable: it reported a net loss of $86.6M over the trailing twelve months.
- What is MBX Biosciences, Inc.'s earnings per share?
- MBX Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.16.
- Where does MBX Biosciences, Inc.'s income statement data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.